Cube Labs SpA
Cube Labs SpA exhibits a capital structure with a market cap of EUR 50.2 million and a price-to-book ratio of 0.85, indicating a discount to tangible book value. The company's liquidity position is characterized by EUR 1.21 million in cash and equivalents, but with a negative net cash position after subtracting total debt of EUR 2.86 million. The current ratio of 1.16 suggests limited short-term liquidity coverage. Profitability metrics show a challenging performance, with a return on equity of -1.23% and a return on assets of -1.15%. The company reported a net loss of EUR 730,750 and an operating loss of EUR 803,140, indicating a lack of operational profitability. These results fall below the typical performance of investment management firms, which usually exhibit positive returns on equity and assets. The company's revenue of EUR 2.01 million is not segmented by geographic region or business line in the provided data, making it difficult to assess revenue concentration. However, the venture builder model implies a focus on innovation and R&D, with potential exposure to global healthcare technology markets. Growth trajectory is not clearly defined in the data, as the outlook for the current and next fiscal years is not provided. The company's operating cash flow of -EUR 1.91 million and free cash flow of -EUR 0.94 million suggest ongoing cash burn, which could limit its ability to scale operations or fund new ventures without external financing. Risk factors include a medium liquidity risk due to the negative net cash position and a current ratio below 2.0. The dilution risk is assessed as low, with no near-term pressure expected. However, the company's capital expenditure of -EUR 0.22 million and ongoing losses may necessitate future financing, which could lead to dilution. Recent events include a strong buy recommendation from one analyst with a mean price target of EUR 3.25, indicating potential upside despite the company's current unprofitable status. No recent filings or transcripts are provided to detail strategic shifts or operational updates.
Business. Cube Labs SpA is an Italy-based venture builder primarily engaged in the healthcare technology industry, creating business from R&D stage and providing entrepreneurial and operational support into healthcare management and technology solutions.
Classification. Cube Labs SpA is classified under the Financials sector, specifically in the Investment Management & Fund Operators industry, with a confidence level of 0.92.
- Cube Labs SpA is a venture builder in healthcare technology with a capital structure showing a discount to book value.
- The company is unprofitable, with negative returns on equity and assets, and a net loss in the latest reporting period.
- Liquidity is constrained by a negative net cash position and a current ratio of 1.16.
- Analysts have issued a strong buy recommendation with a price target of EUR 3.25, suggesting potential for value creation.
- The company's growth trajectory is unclear, with no detailed outlook provided for the current or next fiscal year.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.